Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1992 1
2001 1
2003 1
2004 2
2011 1
2012 1
2013 3
2014 3
2015 1
2016 1
2017 3
2018 3
2019 4
2020 1
2021 1
2022 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

26 results
Results by year
Filters applied: . Clear all
Page 1
GPCR biased ligands as novel heart failure therapeutics.
Violin JD, Soergel DG, Boerrigter G, Burnett JC Jr, Lark MW. Violin JD, et al. Among authors: soergel dg. Trends Cardiovasc Med. 2013 Oct;23(7):242-9. doi: 10.1016/j.tcm.2013.01.002. Epub 2013 Mar 15. Trends Cardiovasc Med. 2013. PMID: 23499300 Review.
Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure).
Felker GM, Butler J, Collins SP, Cotter G, Davison BA, Ezekowitz JA, Filippatos G, Levy PD, Metra M, Ponikowski P, Soergel DG, Teerlink JR, Violin JD, Voors AA, Pang PS. Felker GM, et al. Among authors: soergel dg. JACC Heart Fail. 2015 Mar;3(3):193-201. doi: 10.1016/j.jchf.2014.09.008. Epub 2015 Jan 28. JACC Heart Fail. 2015. PMID: 25650371 Free article. Review.
Is plasma renin activity associated with worse outcomes in acute heart failure? A secondary analysis from the BLAST-AHF trial.
Rachwan RJ, Butler J, Collins SP, Cotter G, Davison BA, Senger S, Ezekowitz JA, Filippatos G, Levy PD, Metra M, Ponikowski P, Teerlink JR, Voors AA, de Boer RA, Soergel DG, Felker GM, Pang PS. Rachwan RJ, et al. Among authors: soergel dg. Eur J Heart Fail. 2019 Dec;21(12):1561-1570. doi: 10.1002/ejhf.1607. Epub 2019 Oct 23. Eur J Heart Fail. 2019. PMID: 31646707 Free article. Clinical Trial.
The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium.
Monasky MM, Taglieri DM, Henze M, Warren CM, Utter MS, Soergel DG, Violin JD, Solaro RJ. Monasky MM, et al. Among authors: soergel dg. Am J Physiol Heart Circ Physiol. 2013 Sep 15;305(6):H856-66. doi: 10.1152/ajpheart.00327.2013. Epub 2013 Jul 19. Am J Physiol Heart Circ Physiol. 2013. PMID: 23873795 Free PMC article.
APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy.
Viscusi ER, Skobieranda F, Soergel DG, Cook E, Burt DA, Singla N. Viscusi ER, et al. Among authors: soergel dg. J Pain Res. 2019 Mar 11;12:927-943. doi: 10.2147/JPR.S171013. eCollection 2019. J Pain Res. 2019. PMID: 30881102 Free PMC article.
26 results